Background: Curcumin, a polyphenol derived from rhizome of Curcuma longa, has been successfully used in animals and humans due to its antibacterial and anti-inflammatory properties. Recently, a study demonstrated that curcumin ointment reduced pain, mammary tension and erythema in humans with mastitis 72 h after the treatment. Mastitis in sheep is an important problem due to restrictions associated to the use of antibiotics, affecting milk production and becoming a public health issue. Thus, the aim of this study was to verify whether the addition of curcumin in the diet of six female sheep with subclinical mastitis could have curative efficacy and benefits to animal health.Cases: Six Lacaune sheep with subclinical mastitis that persisted for more than thirty days after the parturition were used. The animals received feed containing the curcumin (60 mg/animal/day) during 10 days. On days 0 and 10 of the experiment, total blood was collected to perform the hemogram and serum biochemistry (triglycerides, cholesterol, glucose, total protein (TP), albumin, globulin, aspartate aminotransferase (AST) and urea), as well as individual milk samples for centesimal composition, somatic cell count (SCC) and total bacterial count (TBC). Total leukocytes and erythrocytes, as well as hemoglobin content, were obtained using the hematological counter CELM-CC-550. Blood smears were stained by theRomanowsky method and used for leukocytes differentiation. After ten days of treatment, five sheep were negative in the California Mastitis Test (CMT). Total erythrocytes increased, while total leukocytes decreased after the treatment. Seric levels of AST, triglycerides, cholesterol and globulins decreased, while seric levels of albumin and urea increased after tendays of treatment. No differences were observed regarding milk production and composition, as well as for SCC and TBC on days 0 and 10 post treatment.Discussion: The use curcumin to prevent or to delay the occurrence of subclinical mastitis in ewes was first tested. In an experiment of lipopolysaccharide-induced mastitis in rats, researchers identified receptors type Toll 4 which are related with the induction of the synthesis of pro-inflammatory cytokines, as tumor necrosis factor alpha, interleukin-6 and 1β, molecules involved in the migration of leukocytes to the site of inflammation. According to literature, curcumin was able to reduce theactivity of myeloperoxidase in the mammary gland, an enzyme used as indicator of neutrophil infiltration, demonstrating the potent anti-inflammatory effect of curcumin. This effect can be associated to the release of interleukin-8, a cytokine that promotes the migration of neutrophils, lymphocytes and eosinophils into the site of infection, i.e., the mammary gland. It is important to highlight that neutrophils, due to its capacity to release inflammatory mediators and to delay apoptosis, has the potential to maintain a permanent inflammatory process, effects that were prevented or reduced by curcumin, specially the apoptotic and cytotoxic effects. It is important to emphasize the direct effect of curcumin on bacteria present in the mammary gland, since it exerts potent bactericidal effect. In summary, the use of curcumin in sheep with subclinical mastitis exerted beneficial effects in the dose of 60 mg/sheep/day, since it showed 83.3% of curative efficacy in the test CMT. This effect of curcumin can be direct or indirect, since the curcumin provided in the diet showed anti-inflammatory properties byreducing oxidation reactions and cell damage. Overall, the addition of curcumin in sheep diet improved the hematological and biochemical variables after only ten days of treatment. Future studies should be performed to clarify and determine whether the curcumin provided in diet can be an alternative to treat clinical or subclinical mastitis.Keywords: curcumin, mammary infection, immunity, biochemistry parameters, ovine.
The emergence of antibiotic-resistant bacteria in the intestinal microbiota of broiler chickens, and the possibility of antibiotic residues in meat and meat products are seen as a threat to animal and human health. The search for alternatives to conventional drugs, including natural compounds, is an interesting approach to prevent the adverse effects of antibiotics. Therefore, the aim of the present study was to evaluate whether the addition of tannin (as a quebracho extract) in the diet of broiler chickens could be used to replace in-feed antimicrobials and coccidiostatic drugs, to exert positive effects on animal health and performance. The use of tannin in the diet of broiler chicks as an additive (at 0.5% for 1–10-day-old birds; and 1.0% for 11–42-day-old broiler chickens) enhanced their bodyweight, weight gain and daily weight gain on Day 42 of life, compared with the untreated control group (P < 0.05). However, these findings were not observed when tannin was added at 0.5%. Moreover, broiler chickens fed with an extract containing tannins showed higher erythrocyte counts, as well as haemoglobin and haematocrit concentrations than did those in the control group, whereas counts of total leukocytes and lymphocytes were lower (P < 0.05). The use of a diet with tannins did not influence meat quality compared with a diet containing zinc bacitracin and salinomycin, which altered some parameters associated with meat colour. Moreover, the diet with tannins reduced (P < 0.05) the number of oocysts of Eimeria sp. (36-day-old broilers) and the total faecal bacterial counts (42-day-old broilers) compared with the control group. Finally, intestinal histopathology showed that the addition of tannins minimised the degree of lesions (Degree 1) compared with the control group (Degree 3). On the basis of these results, we concluded that the use of quebracho extract containing tannins can be a suitable approach to improve the performance of broiler chickens, replacing in-feed antibiotics and coccidiostatic drugs. The use of tannins did not change meat quality; however, it caused positive effects on the immune system, and exerted potent bactericidal and coccidiostatic properties, reinforcing its use as a replacement for conventional drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.